ES2090966T3 - Formulaciones liposomicas con piroxicam. - Google Patents

Formulaciones liposomicas con piroxicam.

Info

Publication number
ES2090966T3
ES2090966T3 ES93903912T ES93903912T ES2090966T3 ES 2090966 T3 ES2090966 T3 ES 2090966T3 ES 93903912 T ES93903912 T ES 93903912T ES 93903912 T ES93903912 T ES 93903912T ES 2090966 T3 ES2090966 T3 ES 2090966T3
Authority
ES
Spain
Prior art keywords
piroxicam
pct
phospholipid
sec
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93903912T
Other languages
English (en)
Inventor
Giovanni Lucchetti
Giuseppe Assogna
Pietro Bagnato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Cilag SpA
Original Assignee
Janssen Cilag SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Cilag SpA filed Critical Janssen Cilag SpA
Application granted granted Critical
Publication of ES2090966T3 publication Critical patent/ES2090966T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A FORMULACIONES LIPOSOMIALES TOPICAS, COMPRENDIENDO PIROXICAM, UN FOSFOLIPIDO, UN SISTEMA DISOLVENTE PARA PIROXICAM Y EL CITADO FOSFOLIPIDO, AGUA Y AGENTES DE FORMULACIONES AUXILIARES CONVENCIONALES, Y UN METODO PARA PREPARAR LA CITADA FORMULACION.
ES93903912T 1992-02-12 1993-02-04 Formulaciones liposomicas con piroxicam. Expired - Lifetime ES2090966T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200398 1992-02-12

Publications (1)

Publication Number Publication Date
ES2090966T3 true ES2090966T3 (es) 1996-10-16

Family

ID=8210420

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93903912T Expired - Lifetime ES2090966T3 (es) 1992-02-12 1993-02-04 Formulaciones liposomicas con piroxicam.

Country Status (13)

Country Link
US (1) US5505960A (es)
JP (1) JPH07503952A (es)
CN (1) CN1075633A (es)
AT (1) ATE137959T1 (es)
AU (1) AU661755B2 (es)
CA (1) CA2129624A1 (es)
DE (1) DE69302677T2 (es)
DK (1) DK0625898T3 (es)
ES (1) ES2090966T3 (es)
IL (1) IL104688A0 (es)
MX (1) MX9300707A (es)
TW (1) TW262382B (es)
ZA (1) ZA93954B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) * 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
US20100173876A1 (en) * 2000-12-19 2010-07-08 The Board Of Regents Of The University Of Texas System Oil-based nsaid compositions and methods for making and using same
ES2317873T3 (es) * 2000-12-19 2009-05-01 The Board Of Regents, The University Of Texas System Formulaciones antiinflamatorias no esteorideas que comprenden aceites de lecitina para proteger el tracto gastrointestinal y que mejoran la aspividad terapuetica.
CN103143031A (zh) 2003-07-31 2013-06-12 得克萨斯大学体系董事会 用于治疗、预防和/或改善癌症、癌症发病或癌症症状的组合物和方法
US8097626B2 (en) 2006-04-21 2012-01-17 Glaxosmithkline Llc IL-8 receptor antagonists
US8772358B2 (en) * 2008-11-12 2014-07-08 Archer Daniels Midland Co. Lecithin and plasticizer compositions and methods
CN101637451B (zh) * 2009-06-12 2011-03-30 陶灵刚 一种氯诺昔康脂质体药物组合物及其固体制剂
US8956600B2 (en) * 2009-08-10 2015-02-17 Taiwan Liposome Co. Ltd. Ophthalmic drug delivery system containing phospholipid and cholesterol
US8906397B2 (en) 2011-02-07 2014-12-09 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
US8871811B2 (en) 2011-02-07 2014-10-28 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
US20120201871A1 (en) * 2011-02-07 2012-08-09 Professional Compounding Centers Of America, Ltd. Permeation enhancers with liposomes for topical formulations
CN103957888B (zh) 2011-09-29 2017-11-21 PLx 制药公司 用于将药物沿胃肠道靶向释放的pH依赖性载体、其组合物及其制备和应用
US9415054B2 (en) 2013-06-13 2016-08-16 Professional Compounding Centers Of America (Pcca) Piroxicam transdermal composition to treat plantar fasciitis
KR20220158031A (ko) 2020-03-26 2022-11-29 피엘엑스 옵코 인코포레이티드 pH 의존성 재구성이 가능한 제약 담체 및 그의 제조 및 사용 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699230A (en) * 1971-03-12 1972-10-17 Robins Co Inc A H Dimethylisosorbide solvent for muscle relaxant drugs
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
ES2036593T3 (es) * 1986-06-12 1993-06-01 The Liposome Company, Inc. Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US4963297A (en) * 1987-12-22 1990-10-16 The Liposome Company, Inc. Spontaneous vesticulation of multilamellar liposomes
BE1000381A4 (fr) * 1987-03-13 1988-11-16 Pharlyse Sa Preparation pharmaceutique a base d'indometacine.
US4783450A (en) * 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators

Also Published As

Publication number Publication date
AU661755B2 (en) 1995-08-03
MX9300707A (es) 1994-01-31
CA2129624A1 (en) 1993-08-19
DE69302677D1 (de) 1996-06-20
ATE137959T1 (de) 1996-06-15
TW262382B (es) 1995-11-11
CN1075633A (zh) 1993-09-01
IL104688A0 (en) 1993-06-10
ZA93954B (en) 1994-08-11
DK0625898T3 (da) 1996-06-03
AU3495093A (en) 1993-09-03
DE69302677T2 (de) 1996-10-02
US5505960A (en) 1996-04-09
JPH07503952A (ja) 1995-04-27

Similar Documents

Publication Publication Date Title
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
ES2090966T3 (es) Formulaciones liposomicas con piroxicam.
ATE296612T1 (de) Wirkstoffe für die behandlung der senilen xerosis und zubereitungen
IL110121A0 (en) Stable finished formulations for crop protection and their preparation
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
CA2137001A1 (en) Lipids for Epidermal Moisturization and Repair of Barrier Function
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
DE69608896T2 (de) Zubereitungen enthaltend leflunomide
MY131524A (en) Liposomal itraconazole formulations
ES2101860T3 (es) Percarbonato de sodio encapsulado, estable al almacenamiento, y procedimiento para su preparacion.
DK0633763T3 (da) Kosmetiske eller farmaceutiske sammensætninger indeholdende deacylerede glycerophospholipider til topisk brug
DK0637909T3 (es)
NO943567D0 (no) Bruede bis-arylcarbinolderivater, preparater og anvendelsesmetoder
DE50000033D1 (de) Haarwaschmittel
TW248530B (es)
AU1459192A (en) Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
ES2098119T3 (es) Nuevas triazoloquinazolinas, su obtencion y empleo.
DE69215511D1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 625898

Country of ref document: ES

FG2A Definitive protection

Ref document number: 625898

Country of ref document: ES